A critical breakthrough in cancer research is occurring with the use of nanobodies to reactivate damaged p53. This essential malignant protector protein is frequently inactivated in many kinds of tumors, resulting https://bookmarkja.com/story24839537/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-pathway-for-tumor-treatment